Searched for
ONCOLOGY AND NON ONCOLOGY PRODUCTS
Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...- For medium- to long-term investors seeking sustainable growth: 5 large- and mid-caps with upside potential of up to 28%When a market starts to recover, as it is these days, the temptation is to chase whatever is running the fastest (essentially momentum). Bu...
- Manipal Health shares slide 6% on account of profit booking. What should investors do?Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain ...
- KKR buys Medicover’s India hospitals businessGlobal investment firm KKR has acquired Medicover India's hospital business. Sources said the the transaction values the hospital chain at ...
- KKR to acquire Medicover India in $1.5 billion dealThe transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth ...
- Manipal Health Enterprises shares list at 11% premium over IPO price on BSE, NSEManipal Health Enterprises shares debuted on Wednesday with an 11% premium. The IPO garnered strong demand, especially from institutional i...
- Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyFrom AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...
- Manipal Health Enterprises IPO listing tomorrow: Here’s what GMP indicates ahead of market debutManipal Health Enterprises is set to list its Rs 9,275.22 crore mainboard IPO on the BSE and NSE on August 5. With grey market trends indic...
- Manipal Health Enterprises IPO allotment likely today: How to check status, GMP, listing date, key detailsOnce the allotment process is completed, applicants can check whether they have been allotted shares through the registrar, KFin Technologi...
- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...
- Manipal Health IPO booked nearly 5 times on strong QIB push. Check GMP & other key detailsManipal Health Enterprises' Rs 9,275-crore IPO closed with strong demand, subscribed 4.92 times overall. Institutional investors led the su...
- Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest,...
- Can Manipal Health IPO deliver long-term growth for high risk investors?Manipal Health Enterprises plans to raise ₹8,000 crore through a fresh issue for debt repayment and expansion. The company's revenue grew s...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Andhra Pradesh teams up with AstraZeneca for next-gen cancer care modelAndhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial int...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
- India contributes one-third of global oral cancer burden; early detection key to survival, says oral cancer expertIndia contends with a pressing oral cancer crisis, with thousands of new diagnoses and deaths emerging annually. The predominant factor beh...
- Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...
Load More
